MetaCap

Takeda Pharmaceutical Company Limited ADR (TAK)

NYSE: TAKHealth CareBiotechnology: Pharmaceutical PreparationsUSD

21.77+0.36 (+1.68%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

TAK stock chart

Technical analysis

Key statistics

All statistics
Market cap
$69.55B
P/E (TTM)
311.00
Dividend yield
927.88% ($202.00)
Ex-dividend date
Mar 31, 2025
52-week range
14.16 – 22.07
Day range
21.74 – 22.07
Volume / Avg
3.80M / 2.73M
Beta
—
Next earnings
Jan 28, 2027

52-week range

$14.16$22.07

TAK stock today

Takeda Pharmaceutical (TAK) closed at $21.77 on Nov 20, up 1.68% (+$0.36), versus the S&P 500's 3.70% decline. At this level, TAK sits near the top of its 52-week range of $14.16 to $22.07: 1.4% below the high, set on Nov 20, 2026 and 53.7% above the low. TAK is up 39.6% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 52.2%.

At 311.0x trailing earnings, Takeda Pharmaceutical trades above the peer-group median of 43.2x. Its forward P/E of 41.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Takeda Pharmaceutical's next earnings report is expected on Jan 28, 2027. Takeda Pharmaceutical pays an annual dividend of $202.00 per share, a 927.88% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Takeda Pharmaceutical

Company profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enantone, Ninlaro, Iclusig, FRUZAQLA, Alunbrig, vyvanse/elvanse, Trintellix, and QDENGA brands.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Ms. Julie Kim
Headquarters
Chuo
Employees
47,029
IPO year
2018
Website
takeda.com

Analyst forecast

Forecast

Consensus (3 analysts)

strong_buy

Avg. price target

$24.53+12.68%

  • Strong buy 0
  • Buy 3
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $20.78High $26.76

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Jan 28, 2027
Last reported (Sep/2026)
Oct 29, 2026
EPS actual vs est.
$0.44 vs $0.31
Surprise
+41.94%

Dividends

Dividend history
Annual dividend
$202.00
Last payment
$0.339
Ex-dividend date
Mar 31, 2025

TAK news

All TAK news

Takeda Pharmaceutical peers

Health Care sector
TAK peer companies
CompanyPrice% ChgMarket capCompare
TEVATeva Pharmaceutical Industries Limited39.23+1.79%$45.77Bvs TAK
ONCBeOne Medicines Ltd. ADR390.94-2.19%$44.66Bvs TAK
REGNRegeneron Pharmaceuticals Inc.920.69-0.19%$95.24Bvs TAK
GSKGSK plc ADR47.76-0.13%$95.73Bvs TAK
RPRXRoyalty Pharma plc Class A68.45+1.08%$39.36Bvs TAK
ZTSZoetis Inc. Class A79.11-2.08%$32.14Bvs TAK
GMABGenmab A/S ADS50.60-1.46%$31.20Bvs TAK
INSMInsmed Incorporated141.33-2.17%$31.01Bvs TAK

Indexes, lists and sector

Takeda Pharmaceutical stock FAQ

What is Takeda Pharmaceutical's stock price today?

TAK last traded at $21.77 as of Nov 20, 4:00 PM EST, up 1.68% on the day. Prices are delayed at least 15 minutes.

Does Takeda Pharmaceutical pay a dividend?

Yes. Takeda Pharmaceutical pays $202.00 per share annually, a 927.88% yield. The most recent dividend of $0.339 had an ex-dividend date of Mar 31, 2025.

When is Takeda Pharmaceutical's next earnings date?

Takeda Pharmaceutical is expected to report earnings on Thursday, January 28, 2027.

What is TAK's P/E ratio?

TAK trades at a trailing P/E ratio of 311.00 and a forward P/E of 41.08, compared with a median of 43.2 for its closest peers.

Who is Takeda Pharmaceutical's CEO?

Ms. Julie Kim is the chief executive officer of Takeda Pharmaceutical Company Limited ADR, which has about 47,029 employees.

What is the TAK 52-week high?

The 52-week high for TAK is $22.07 and the 52-week low is $14.16. The stock is currently 1.4% below its high.

Compare TAK